Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Icu Medical (ICUI) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to -$3.4 million.

  • Icu Medical's Profit After Tax rose 8970.38% to -$3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.4 million, marking a year-over-year increase of 9336.8%. This contributed to the annual value of -$117.7 million for FY2024, which is 29685.72% down from last year.
  • Per Icu Medical's latest filing, its Profit After Tax stood at -$3.4 million for Q3 2025, which was up 8970.38% from $35.3 million recorded in Q2 2025.
  • Over the past 5 years, Icu Medical's Profit After Tax peaked at $35.3 million during Q2 2025, and registered a low of -$39.5 million during Q1 2024.
  • Over the past 5 years, Icu Medical's median Profit After Tax value was -$9.9 million (recorded in 2023), while the average stood at -$5.4 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first plummeted by 55569.22% in 2024, then soared by 26508.46% in 2025.
  • Over the past 5 years, Icu Medical's Profit After Tax (Quarter) stood at $19.9 million in 2021, then tumbled by 177.97% to -$15.5 million in 2022, then decreased by 10.37% to -$17.1 million in 2023, then tumbled by 38.96% to -$23.8 million in 2024, then soared by 85.75% to -$3.4 million in 2025.
  • Its last three reported values are -$3.4 million in Q3 2025, $35.3 million for Q2 2025, and -$15.5 million during Q1 2025.